Similar Articles |
|
Chemistry World September 24, 2015 |
A new hope in HIV prevention New microbicide products could turn the tide against Aids for those who need it most: women in sub-Saharan Africa. Dinsa Sachan reports. |
Chemistry World August 4, 2008 Pete Mitchell |
Vaccine failures shake up HIV research Prospects for an HIV vaccine have receded with the July decision by the US government National Institutes of Health (NIH) to cancel trials of its main vaccine candidate. |
Chemistry World February 9, 2007 Victoria Gill |
Africa's First Large-Scale HIV Vaccine Trial The first large-scale clinical trial of an HIV vaccine will involve around 3000 participants in five selected sites in South Africa. It will compare the effectiveness of the vaccine at reducing HIV infection compared to a placebo. |
AskMen.com |
Vaccine Helps Prevent HIV For the first time, an experimental vaccine has prevented infection with the AIDS virus, a watershed event in the deadly epidemic and a surprising result. |
The Motley Fool September 25, 2007 Brian Orelli |
Cold HIV Vaccine Gets Frozen Phase 2 clinical trials of Merck's HIV vaccine were frozen, leaving the door open for other drugmakers that have vaccines of their own in early trials. Investors, take note. |
Scientific American October 2008 John Rennie |
Hope and the Fight against HIV The battle must continue, even if 25 years of research have disappointed. |
Fast Company August 8, 2011 Kate Rockwood |
AIDS Vaccine Conference Despite billions in annual research dollars, the quest for an AIDS vaccine remains elusive. |
Chemistry World March 10, 2008 Victoria Gill |
New Hope for Anti-HIV Gels Early data from a clinical trial has rekindled hope of an effective topical gel to prevent HIV infection. |
Salon.com June 26, 2000 Arthur Allen |
Mad scientist A grand jury is looking into the double life of Larry C. Ford, a brilliant doctor who killed himself before others learned about his dark side. |
Chemistry World March 5, 2007 Victoria Gill |
Protein Stops HIV Infection in its Tracks Researchers have identified a protein that might help explain why promising microbicide gels are yet to prove effective against HIV transmission. |
Bio-IT World May 7, 2002 Davies & Levitt |
Bridge Over Troubled Waterford Project For a project that links some of the best institutions and minds in AIDS research in order to produce an effective vaccine that could save millions of lives, funding should be a nonissue. Unfortunately, that is not the case -- and the bio-IT community has to find a way to remedy this issue. |
Pharmaceutical Executive June 1, 2005 Seth Berkley |
Backpage: Partnering for Vaccine Victories Public-private partnerships can help engage industry in AIDS vaccine research. Pharma and biotechnology companies should respond with the expertise that only they can offer. |
ifeminists July 28, 2004 Wendy McElroy |
AIDS Efforts Undermined by U.N. Politics Politics lies at the root of the U.N.'s constant bashing of American policies. In the shifting vista of AIDS politics, where even the figures are blurring, the U.S. is correct and prudent to withhold its support. |
AskMen.com Ross Bonander |
5 Things You Didn't Know: Condoms In an effort to give their profile a boost, here's a look at five things you didn't know about condoms. |
Smithsonian November 2005 |
35 Who Made a Difference: Bill Gates The king of software takes on his biggest challenge yet: his foundation is reshaping the landscape of deadly and debilitating diseases in the developing world. |